IMU Biosciences

IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune system across health and disease.

Its platform can identify and analyse over 2,000 immune cell subsets from blood samples, generating predictive signatures for disease monitoring.

Applications span immuno-oncology, transplantation, autoimmune disease, and cell therapy development.

IMU partners with pharmaceutical companies and is a key contributor to the MANIFEST immunotherapy research consortium.